Chambers Rebecca
Veracyte Inc · Chief Financial Officer
Chambers Rebecca is listed in filings as Chief Financial Officer at Veracyte Inc. This profile follows SEC Form 4 activity through Jun 4, 2026, including sale activity. Recent filings connect the profile to Veracyte Inc (VCYT) and Inari Medical, Inc. (NARI). The current snapshot covers public activity from Jun 24, 2024 to Jun 4, 2026. Reported amounts are shown as $98.2K to $176.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $506k13.9k shares | SellMar 4, 2026 | $36.33 | $59.22 | |
| $156k4.4k shares | SellMar 4, 2026 | $35.55 | $59.22 | |
| $398k8.5k shares | SellDec 4, 2025 | $46.61 | $59.22 | |
| $224k4.7k shares | SellDec 4, 2025 | $47.25 | $59.22 | |
| $287k7k shares | SellNov 5, 2025 | $41.00 | $59.22 | |
| $23k527 shares | SellFeb 3, 2025 | $43.85 | $59.22 | |
| $303k7k shares | SellDec 3, 2024 | $43.23 | $59.22 | |
| $586k15.3k shares | SellNov 12, 2024 | $38.34 | $59.22 | |
| $12k260 shares | SellJun 21, 2024 | $45.99 | $79.97 |